Related Experiment Video
Updated: Mar 9, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Concomitant mitral annular calcification and severe aortic stenosis: prevalence, characteristics and outcome
Yigal Abramowitz1, Yoshio Kazuno1, Tarun Chakravarty1
1The Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Insights
Mitral annular calcification (MAC) affects nearly half of patients undergoing transcatheter aortic valve replacement (TAVR). Severe MAC independently predicts higher mortality and pacemaker implantation post-TAVR, necessitating its inclusion in risk models.
Area of Science:
- Cardiology
- Medical Imaging
- Interventional Cardiology
Background:
- Mitral annular calcification (MAC) shares etiological and pathophysiological links with aortic stenosis (AS).
- MAC is commonly observed in computed tomography (CT) scans before transcatheter aortic valve replacement (TAVR).
- The prognostic significance of MAC in TAVR patients remains under-investigated.
Purpose of the Study:
- To determine the prevalence of MAC in patients with severe AS undergoing TAVR.
- To evaluate the clinical impact of MAC on outcomes during and after TAVR.
Main Methods:
- A cohort of 761 patients undergoing TAVR was analyzed.
- Patients were stratified based on the presence and severity of MAC identified in pre-TAVR CT scans.
- Multivariable survival analysis was employed to assess predictors of mortality and complications.
Main Results:
- MAC was present in 49.3% of patients; severe MAC was identified in 9.5%.
- Thirty-day mortality and major complications did not differ significantly between patients with and without MAC.
- Severe MAC independently predicted increased all-cause and cardiovascular mortality (HR 1.95 and 2.35, respectively).
- Severe MAC also predicted the need for permanent pacemaker implantation (PPI) post-TAVR (OR 2.83).
Conclusions:
- MAC is highly prevalent in patients with severe AS evaluated for TAVR.
- Severe MAC is a significant independent predictor of adverse outcomes, including mortality and conduction abnormalities.
- Incorporating MAC assessment into TAVR risk stratification models is recommended.
Aims:
Calcified aortic stenosis (AS) and mitral annular calcification (MAC) have certain similar etiology and pathophysiological mechanisms. MAC is frequently encountered in pre-procedural computed tomography (CT) imaging of patients that undergo transcatheter aortic valve replacement (TAVR), but its prognostic implications for these patients have not been thoroughly investigated. This study sought to evaluate the prevalence of MAC among patients with severe AS and to assess the clinical implications of MAC on these patients during and following TAVR.
Methods And Results:
Consecutive patients that underwent TAVR were compared according to the existence of MAC and its severity in pre-TAVR CT scans. From the entire cohort of 761 patients, 49.3% had MAC, and 50.7% did not have MAC. Mild MAC was present in 231 patients (30.4%), moderate MAC in 72 patients (9.5%), and severe MAC in 72 patients (9.5%). Thirty-day mortality and major complications were similar between patients with and without MAC. In a multivariable survival analysis, severe MAC was found to be an independent strong predictor of overall mortality following TAVR (all-cause mortality: hazards ratio [HR] 1.95, 95% confidence interval [CI] 1.24-3.07, P = 0.004; cardiovascular mortality: HR 2.35, 95% CI 1.19-4.66; P = 0.01). Severe MAC was also found to be an independent strong predictor of new permanent pacemaker implantation (PPI) after TAVR (OR 2.83, 95% CI 1.08-7.47; P = 0.03).
Conclusion:
Half of the patients with severe AS evaluated for TAVR were found to have MAC. Severe MAC is associated with increased all-cause and cardiovascular mortality and with conduction abnormalities following TAVR and should be included in future risk stratification models for TAVR.
Related Concept Videos
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis III: Medical Management
Aortic Regurgitation III: Medical Management
Aortic Regurgitation I: Introduction

